107 related articles for article (PubMed ID: 15756419)
1. Alterations of lymphoid enhancer factor-1 isoform expression in solid tumors and acute leukemias.
Wang W; Ji P; Steffen B; Metzger R; Schneider PM; Halfter H; Schrader M; Berdel WE; Serve H; Müller-Tidow C
Acta Biochim Biophys Sin (Shanghai); 2005 Mar; 37(3):173-80. PubMed ID: 15756419
[TBL] [Abstract][Full Text] [Related]
2. Identification of MYCBP as a beta-catenin/LEF-1 target using DNA microarray analysis.
Jung HC; Kim K
Life Sci; 2005 Jul; 77(11):1249-62. PubMed ID: 15979100
[TBL] [Abstract][Full Text] [Related]
3. Relative expression of different Ikaros isoforms in childhood acute leukemia.
Meleshko AN; Movchan LV; Belevtsev MV; Savitskaja TV
Blood Cells Mol Dis; 2008; 41(3):278-83. PubMed ID: 18675565
[TBL] [Abstract][Full Text] [Related]
4. Coordinated expression of cyclin D1 and LEF-1/TCF transcription factor is restricted to a subset of hepatocellular carcinoma.
Schmitt-Graeff A; Ertelt-Heitzmann V; Allgaier HP; Olschewski M; Nitschke R; Haxelmans S; Koelble K; Behrens J; Blum HE
Liver Int; 2005 Aug; 25(4):839-47. PubMed ID: 15998435
[TBL] [Abstract][Full Text] [Related]
5. E-cadherin is required for caveolin-1-mediated down-regulation of the inhibitor of apoptosis protein survivin via reduced beta-catenin-Tcf/Lef-dependent transcription.
Torres VA; Tapia JC; Rodriguez DA; Lladser A; Arredondo C; Leyton L; Quest AF
Mol Cell Biol; 2007 Nov; 27(21):7703-17. PubMed ID: 17785436
[TBL] [Abstract][Full Text] [Related]
6. CD200: a putative therapeutic target in cancer.
Moreaux J; Veyrune JL; Reme T; De Vos J; Klein B
Biochem Biophys Res Commun; 2008 Feb; 366(1):117-22. PubMed ID: 18060862
[TBL] [Abstract][Full Text] [Related]
7. Dominant negative isoform of the Ikaros gene in patients with adult B-cell acute lymphoblastic leukemia.
Nakase K; Ishimaru F; Avitahl N; Dansako H; Matsuo K; Fujii K; Sezaki N; Nakayama H; Yano T; Fukuda S; Imajoh K; Takeuchi M; Miyata A; Hara M; Yasukawa M; Takahashi I; Taguchi H; Matsue K; Nakao S; Niho Y; Takenaka K; Shinagawa K; Ikeda K; Niiya K; Harada M
Cancer Res; 2000 Aug; 60(15):4062-5. PubMed ID: 10945610
[TBL] [Abstract][Full Text] [Related]
8. Beta-catenin can act as a nuclear import receptor for its partner transcription factor, lymphocyte enhancer factor-1 (lef-1).
Asally M; Yoneda Y
Exp Cell Res; 2005 Aug; 308(2):357-63. PubMed ID: 15936755
[TBL] [Abstract][Full Text] [Related]
9. Expression of Hsp90 chaperone [corrected] proteins in human tumor tissue.
McDowell CL; Bryan Sutton R; Obermann WM
Int J Biol Macromol; 2009 Oct; 45(3):310-4. PubMed ID: 19576239
[TBL] [Abstract][Full Text] [Related]
10. MUC1 gene overexpressed in breast cancer: structure and transcriptional activity of the MUC1 promoter and role of estrogen receptor alpha (ERalpha) in regulation of the MUC1 gene expression.
Zaretsky JZ; Barnea I; Aylon Y; Gorivodsky M; Wreschner DH; Keydar I
Mol Cancer; 2006 Nov; 5():57. PubMed ID: 17083744
[TBL] [Abstract][Full Text] [Related]
11. Sequence, "subtle" alternative splicing and expression of the CYYR1 (cysteine/tyrosine-rich 1) mRNA in human neuroendocrine tumors.
Vitale L; Frabetti F; Huntsman SA; Canaider S; Casadei R; Lenzi L; Facchin F; Carinci P; Zannotti M; Coppola D; Strippoli P
BMC Cancer; 2007 Apr; 7():66. PubMed ID: 17442112
[TBL] [Abstract][Full Text] [Related]
12. Keratinocyte transcriptional regulation of the human c-Myc promoter occurs via a novel Lef/Tcf binding element distinct from neoplastic cells.
Kolly C; Zakher A; Strauss C; Suter MM; Müller EJ
FEBS Lett; 2007 May; 581(10):1969-76. PubMed ID: 17466981
[TBL] [Abstract][Full Text] [Related]
13. Dysregulated expression of P1 and P2 promoter-driven hepatocyte nuclear factor-4alpha in the pathogenesis of human cancer.
Tanaka T; Jiang S; Hotta H; Takano K; Iwanari H; Sumi K; Daigo K; Ohashi R; Sugai M; Ikegame C; Umezu H; Hirayama Y; Midorikawa Y; Hippo Y; Watanabe A; Uchiyama Y; Hasegawa G; Reid P; Aburatani H; Hamakubo T; Sakai J; Naito M; Kodama T
J Pathol; 2006 Apr; 208(5):662-72. PubMed ID: 16400631
[TBL] [Abstract][Full Text] [Related]
14. N- and C-terminal isoforms of Arg quantified by real-time PCR are specifically expressed in human normal and neoplastic cells, in neoplastic cell lines, and in HL-60 cell differentiation.
Perego RA; Corizzato M; Bianchi C; Eroini B; Bosari S
Mol Carcinog; 2005 Apr; 42(4):229-39. PubMed ID: 15765532
[TBL] [Abstract][Full Text] [Related]
15. Quantitative and spatial measurements of telomerase reverse transcriptase expression within normal and malignant human breast tissues.
Hines WC; Fajardo AM; Joste NE; Bisoffi M; Griffith JK
Mol Cancer Res; 2005 Sep; 3(9):503-9. PubMed ID: 16179497
[TBL] [Abstract][Full Text] [Related]
16. Variation of LEF-1 mRNA expression in low-grade B-cell non-Hodgkin's lymphoma.
Howe D; Bromidge T
Leuk Res; 2006 Jan; 30(1):29-32. PubMed ID: 16054689
[TBL] [Abstract][Full Text] [Related]
17. LEF-1 is a decisive transcription factor in neutrophil granulopoiesis.
Skokowa J; Welte K
Ann N Y Acad Sci; 2007 Jun; 1106():143-51. PubMed ID: 17360796
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of ERM/ETV5 correlates with the degree of myometrial infiltration in endometrioid endometrial carcinoma.
Planagumà J; Abal M; Gil-Moreno A; Díaz-Fuertes M; Monge M; García A; Baró T; Xercavins J; Reventós J; Alameda F
J Pathol; 2005 Dec; 207(4):422-9. PubMed ID: 16175655
[TBL] [Abstract][Full Text] [Related]
19. Silencing of MBD1 and MeCP2 in prostate-cancer-derived PC3 cells produces differential gene expression profiles and cellular phenotypes.
Yaqinuddin A; Abbas F; Naqvi SZ; Bashir MU; Qazi R; Qureshi SA
Biosci Rep; 2008 Dec; 28(6):319-26. PubMed ID: 18666890
[TBL] [Abstract][Full Text] [Related]
20. A novel cervical cancer suppressor 3 (CCS-3) interacts with the BTB domain of PLZF and inhibits the cell growth by inducing apoptosis.
Rho SB; Park YG; Park K; Lee SH; Lee JH
FEBS Lett; 2006 Jul; 580(17):4073-80. PubMed ID: 16828757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]